Atlas Trials

Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes

Clinical trial NCT02360254 · COMPLETED

Trial details

NCT number
NCT02360254
Sponsor
University of Padova
Status
COMPLETED
Study type
OBSERVATIONAL
Type 1 Diabetes Mellitus
Start date
2015-01-01
Primary completion
2016-01-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.